Sustained viral suppression among participants with pre-existing M184V/I who switched to bictegravir/emtricitabine/tenofovir alafenamide
Authors
Andreatta, K; Acosta, R; D'Antoni, M; Porter, D; Chang, S; Martin, R; Willkom, M; McNicholl, I; Gallant, J; Pikora, CCollections
- Centre for Immunobiology [1121]